AZD1390 Administration of a Microdose [11C]AZD1390 to healthy volunteers

Trial Identifier:	D6940C00001
Sponsor:	AstraZeneca
Collaborator:	Karolinska Institutet, Quintiles IMS
NCTID::	NCT03215381
Start Date:	October 2017
Primary Completion Date:	February 2018
Study Completion Date:	February 2018

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Translation
	Swedish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Sweden	Stockholm, Sweden, 171 76

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.